Research aimed to overcome the intracableness of lung fibrosis by regulation of ageing-related long non-coding RNAs
Project/Area Number |
18K15948
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 53030:Respiratory medicine-related
|
Research Institution | Nagoya University |
Principal Investigator |
Koji Sakamoto 名古屋大学, 医学部附属病院, 病院講師 (00635633)
|
Project Period (FY) |
2018-04-01 – 2023-03-31
|
Project Status |
Completed (Fiscal Year 2022)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2020: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 肺線維症 / エピゲノム / RNA / 細胞老化 / 老化 / lncRNA / ミトコンドリアDNA / RNA / リプログラミング / ノンコーディングRNA / エピジェネティクス / 非コードRNA |
Outline of Final Research Achievements |
While the importance of cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis, an age-related intractable disease, has attracted much attention, the involvement of long non-coding RNAs (lncRNAs), a new epigenomic factor responsible for cellular fate determination including cellular senescence, remains unclear. We identified a number of lncRNAs that are specifically altered in idiopathic pulmonary fibrosis based on a large-scale comprehensive RNA expression analysis of human lung tissue. We subsequently extracted several lncRNAs that are also involved in cellular senescence. Among them, we focused on FENDRR, a lncRNA specifically expressed in mesenchymal cells, functions to regulate the cellular senescence phenotype of fibroblasts induced by stimuli such as TGF-β and oxidative stress, which is assumed to be mediated partly by the regulation of NADPH oxidase.
|
Academic Significance and Societal Importance of the Research Achievements |
肺線維症の肺組織で発現変化する新規エピゲノム因子・長鎖ノンコーディングRNAが肺細胞において病態形成に関係した病的な細胞変化、特に細胞老化の表現型を制御していることが示唆された。本研究の更なる発展により難治の肺疾患において長鎖ノンコーディングRNAを用いた同疾患の新しい治療標的の開発やバイオマーカーの創出が期待される。
|
Report
(6 results)
Research Products
(30 results)
-
-
-
-
-
-
-
[Journal Article] A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases2022
Author(s)
Furukawa T, Oyama S, Yokota H, Kondoh Y, Kataoka K, Johkoh T, Fukuoka J, Hashimoto N,Sakamoto K, Shiratori Y, Hasegawa Y
-
Journal Title
Respirology
Volume: 27
Issue: 9
Pages: 739-746
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Size and surface modification of silica nanoparticles affect the severity of lung toxicity by modulating endosomal ROS generation in macrophages2021
Author(s)
Masahide Inoue, Koji Sakamoto, Atsushi Suzuki, Shinya Nakai, Akira Ando, Yukihiko Shiraki, Yoshio Nakahara, Mika Omura, Atsushi Enomoto, Ikuhiko Nakase, Makoto Sawada, Naozumi Hashimoto
-
Journal Title
Particle and Fibre Toxicology
Volume: 18
Issue: 1
Pages: 21-21
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis2021
Author(s)
Nakahara Y, Hashimoto N, Sakamoto K, Enomoto A, Adams TS, Yokoi T, Omote N, Poli S, Ando A, Wakahara K, Suzuki A, Inoue M, Hara A, Mizutani Y, Imaizumi K, Kawabe T, Rosas IO, Takahashi M, Kaminski N, Hasegawa Y.
-
Journal Title
European Respiratory Journal
Volume: 58
Issue: 6
Pages: 2003397-2003397
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Long noncoding RNA TINCR is a novel regulator of human bronchial epithelial cell differentiation state.2021
Author(s)
Omote N, Sakamoto K, Li Q, Schupp JC, Adams T, Ahangari F, Chioccioli M, DeIuliis G, Hashimoto N, Hasegawa Y, Kaminski N.
-
Journal Title
Physiol Rep.
Volume: 9
Issue: 3
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
[Presentation] Meflin-BMP3b Axis Is a Novel Anti-Fibrotic Pathway Against TGF-βInduced Lung Fibrogenesis2022
Author(s)
A. Suzuki , K. Sakamoto , Y. Nakahara , A. Enomoto , J. Hino , A. Ando , M. Inoue , N. Omote , M. Kusaka , J. Fukihara , N. Hashimoto
Organizer
American Thoracic Society 2022 International Conference
Related Report
Int'l Joint Research
-
[Presentation] Increased Circulating Mitochondrial DNA Content Predicts Fatal Complication and Worse Prognosis in Idiopathic Pulmonary Fibrosis2020
Author(s)
K. Sakamoto, T. Furukawa, Y. Yamano, R. Teramachi, A. Suzuki, Y. Nakahara, M. Inoue, K. Kataoka, N. Hashimoto, Y. Kondoh, Y. Hasegawa
Organizer
American Thoracic Society 2020 International Conference
Related Report
Int'l Joint Research
-
-
-
-
[Presentation] Pirfenidone Delays the Prescription of Concomitant Drugs in Patients with Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Japanese Phase III Clinical Trial2020
Author(s)
A. Suzuki, H. Sakaguchi, M. Ebina, A. Azuma, T. Ogura, Y. Taguchi, M. Suga, H. Takahashi, Y. Sugiyama, S. Kudoh, T. Nukiwa , S. Miyazawa, K. Sakamoto, Y. Kondoh
Organizer
American Thoracic Society 2020 International Conference
Related Report
Int'l Joint Research
-
-
-
[Presentation] TINCR, a Long Intergenic Noncoding RNA Decreased in IPF, Is a Novel Regulator of Airway Epithelial Cell Differentiation2019
Author(s)
N. Omote, K. Sakamoto, Q. Li, J. C. Schupp, T. Adams, F. Ahangari, M. Chioccioli, N. Xylourgidis, G. DeIuliis, N. Hashimoto, Y. Hasegawa, N. Kaminski
Organizer
American Thoracic Society 2019 International Conference
Related Report
Int'l Joint Research
-
-
-